Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma (CROSBI ID 136834)

Prilog u časopisu | ostalo

Buljevac, Mladen ; Romić, Željko ; Vucelić, Boris ; Banić, Marko ; Krznarić, Željko ; Pleško, Sanja Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma // Acta medica Croatica, 50 (1996), 11-14-x

Podaci o odgovornosti

Buljevac, Mladen ; Romić, Željko ; Vucelić, Boris ; Banić, Marko ; Krznarić, Željko ; Pleško, Sanja

engleski

Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma

The aim of the study was to investigate the serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma. A total of 59 patients, 49 with liver cirrhosis and 10 with liver cirrhosis and coexistent hepatocellular carcinoma, as well as 202 healthy volunteers entered the study. In the patients with liver cirrhosis and in those with liver cirrhosis and coexistent hepatocellular carcinoma, serum selenium concentrations were significantly lower (39.28+/-13.99 and 42.00+/-10.59 g/L, respectivly), when compared to the group of healthy volunteers (66.79+/-9.13 g/L)(p<0.001). There was no significant difference in serum selenium concentrations between the two patient groups. In the group of patients with liver cirrhosis positive correlation was found between serum and albumin concentrations, and negative correlation between serum selenium and billirubin (p<0.05 and p<0.01, respectively). There was no correlation of serum selenium concentration with fibrinogen and prothrombin time. Results of the study suggested the possible important nutritive and protective role of selenium in the patients with liver cirrhosis and coexistent hepatocellular carcinoma, as well as the potential need of selenium supplementation in these patients.

selenium in serum; liver cirrhosis; liver cirrhosis and hepatocellular carcinoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

50

1996.

11-14-x

objavljeno

1330-0164

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost